Two directors of OSI Debabarrena vaccinated
- Two directors of the Debabarrena Integrated Health Organization (OSI) (Gipuzkoa), Iratxe Ocerín and Ana Bereziartua, have resigned, as confirmed by ARGIA. He is Medical Director of the Mendaro Hospital and Nursing Director of the Eibar Hospital. Both have left office after receiving the COVID-19 vaccine, amid the controversy it has generated.
Two further resignations for irregular vaccination in centers in Osakidetza, Iratxe Ocerin and Ana Bereziartua, of the Board of the Integrated Health Organization OSI Debabarrena, have resigned for having violated the vaccination criteria and having received the vaccine.
The Health Advisor, Gotzone Sagardui, said at a press conference on Wednesday that members of Debabarrena's management team put the vaccine, including the nursing director and the resigned medical director. According to Sagardui, despite having management positions, they carry out an activity related to COVID-19 and were within the vaccination criteria.
OSI is responsible for the management of health services for the population over 76 years of age. This region comprises the following municipalities: Ermua and Mallabia from Bizkaia, and Eibar, Soraluze, Elgoibar, Mendaro, Deba and Mutriku from Gipuzkoa.
The case of the hospitals in Basurto and Santa Marina in Bilbao has shown the irregular distribution of vaccines. After being aware of these cases, the hospital management has recognized that some workers of the hospital in Santiago de Vitoria-Gasteiz who were not vaccinated according to the established criteria have been vaccinated. In the latter case, two OSI Debabarrena managers have resigned.
EH Bildu has called for the resignation of the Health Advisor and all those responsible for the cases in the Basque Country.
The counsellor Sagardui and the director of Osakidetza have to resign, they cannot follow another minute in their duties. ❗ Information has been hidden from us and lied.#VIP vaccines pic.twitter.com/AfNmErGyG7
— EH Bildu (@ehbildu) January 28, 2021
(We completed the news)
Janssen farmazia multinazioanalak txertoaren ikerketa bertan behera uzteko erabakia hartu du, batzorde batek ondorioztatu ostean txertoak ez dituela giza immunoeskasiaren birusari aurre egiteko baldintzak betetzen.
Farmazia enpresa alemaniarrak hamar mila milioi euro irabazi ditu Covid-19aren aurkako txertoen patenteei esker. Hainbat ikerketak frogatu dute farmazeutiken lobbyek oztopatu dituztela patenteak askatzeko akordioak. BioNTechek sare sozialetako mezuak zentsuratu nahi izan ditu,... [+]
COVID-19 kasuek gora egin dute Europan eta 60 eta 79 urte artekoei eta gaitza larri pasatzeko arrisku handiagoa dutenei txertoaren laugarren dosia “berehala” jartzea gomendatu dute Sendagaien Europako Agentziak (EMA) eta Gaixotasunen Prebentziorako eta Kontrolerako... [+]
Erresuma Batuko Airfinity datu analizatzaileak aurreikusi du Europar Batasunak eta G7ko estatuek erositako milioika txerto dosi xahutuko direla erabili aurretik; ohartarazi dute banaketa arazoengatik izan litekeela. UNICEFek jakinarazi du herrialde pobretuek uko egin zietela 100... [+]
Nafarroako Osasun Publikoaren eta Lan Osasunaren Institutuaren azken txostenaren arabera, COVID-19ak eragindako heriotza kopurua oraingoaren bikoitza izango litzateke, haren kontrako txertoaren kanpaina martxan jarri ez balitz.
Many of the decisions of this pandemic need transparent, free and in-depth discussions. We should discuss infant vaccination against COVID-19, as the work on this Seminar on Innovation in Primary Care (SIAP) and the Spanish Network of Primary Care (REAP) have made clear.
The... [+]
Patenteetatik libre dagoen COVID-19aren aurkako txerto berri bat sortu du Texasko haurrentzako ospitaleko txertoen garapenerako zentroak (AEB). Indiak dagoeneko onartu du txerto hori erabiltzeko emergentziazko baimena eta haren sortzaileek espero dute laster Indonesian,... [+]
COVID-19ari dagokionez, abenduaren 22an hasi dute umeei zuzenduriko "hautuzko txertaketa" Ipar Euskal Herrian. Desadostasunak eta ulertu ezinak areagotzen ditu azken neurri honek.
Ayoade Alakija Afrikako Batasuneko presidentekideak salatu du omikron aldaera txertoen banaketa desorekatuaren ondorioz sortu dela. Bestalde, EMAk bosgarren txertoaren merkaturatzea onetsi du, “eraginkorra, kalitatezkoa eta segurua” dela baieztatuta; oraindik ez... [+]